Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Suicide: E.H.S.S.A. - An Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool for Accurately Predicting, in a Specific Patient, the Risk of Suicide in the Reasonably Foreseeable Future. (EHSSA)

NCT04888533 is registered in ClinicalTrials.gov with Care Plus NJ, Inc. as lead sponsor.

NCT NCT04888533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Suicide: E.H.S.S.A. - An Efficient, Holistic, Heuristic and Semi-structured Suicide Assessment Tool for Accurately Predicting, in a Specific Patient, the Risk of Suicide in the Reasonably Foreseeable Future. (EHSSA)
Lead sponsor
Care Plus NJ, Inc.
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
January 31, 2020
Enrollment
1,505 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicide risk